-YFP mice that transcribe YFP (yellow fluorescent protein) directed by the renin promoter. We also followed the expression of Akr1b7 and miR-330-5p, markers of cells programmed for the renin phenotype. Contrary to what we expected, renin null cells did not die or disappear. Instead, they survived, increased in number along the renal arterial tree, and maintained an active molecular memory of the myoepitheliod renin phenotype. Furthermore, null cells of the renin lineage occupied the walls of the arteries and arterioles in a chaotic, directionless pattern directly contributing to the concentric arterial hypertrophy. 
) display several morphological and physiological abnormalities, including poorly developed renal medulla, papillary atrophy, hydronephrosis, inability to concentrate the urine, polyuria, polydipsia, renal failure, and anemia. 1 Underlying such complex phenotype is the presence of unique renal vascular abnormalities: the renal arterioles do not branch or elongate properly, and the affected vessels show concentric arteriolar hypertrophy. 1 Similar vascular abnormalities are found in mice with genomic deletions of any of the genes of the reninangiotensin system (RAS), including the angiotensinogen, [2] [3] [4] [5] angiotensin I-converting enzyme, [6] [7] [8] angiotensin II type 1A and 1B receptor, 9 and aldosterone synthase 10 genes. Analogous abnormalities were previously found in animals treated early in life with RAS inhibitors. 11, 12 Equally important, humans with mutations of the RAS genes also display similar morphological abnormalities, including the hallmark of concentric arteriolar hypertrophy. 13 This vascular lesion, although central to the phenotype, has been difficult to understand from a physiopathological point of view because it has usually been considered a hallmark of hypertensive vascular disease. However, in all the examples mentioned above, the subjects are hypotensive.
An opportunity for understanding arose from experiments in which the renin cells were ablated in mice using diphtheria toxin genetically engineered to be expressed under the control of the renin gene (Ren1d-DTA mice).
14 Because the arterial thickening disappeared with ablation of renin cells, we hypothesized that renin cell precursors contributed to the pathology. Normally, renin cells are identified by the detection of either renin or its mRNA. However, Ren1 c−/− mice cannot make either of them. Because we could not mark/identify the renin null cells, we were uncertain whether renin null cells remained or disappeared from the kidneys of renin knockout mice. However, if the cells were present in the kidney even though they could not make renin, it may indicate that the molecular program for the renin phenotype may be still active although hidden to us because of the lack of tools to track the cells. We therefore genetically engineered several mouse lines to trace the fate of renin null cells and their precursors and test the activity of the renin promoter in vivo using fluorescent reporter constructs. Using those tools and specific renin-independent antibodies and in situ hybridization, we tested whether renin null cells (1) persist and maintain the program of the renin phenotype and (2) contribute directly to the vascular disease.
Abstract-Experimental or spontaneous genomic mutations of the renin-angiotensin system or its pharmacological inhibition in early life leads to renal abnormalities, including poorly developed renal medulla, papillary atrophy, hydronephrosis, inability to concentrate the urine, polyuria, polydipsia, renal failure, and anemia. At the core of such complex phenotype is the presence of unique vascular abnormalities: the renal arterioles do not branch or elongate properly and they have disorganized, concentric hypertrophy. This lesion has been puzzling because it is often found in hypertensive individuals whereas mutant or pharmacologically inhibited animals are hypotensive. 19 Expression of Lac-Z was detected using the X-gal reaction. 20, 21 Using this strategy, all renin cell precursors are permanently labeled blue. 22 Similarly, we generated Ren1 c−/− ;Ren1 c -Cre;R26R.mTmG mice, in which on recombination, cells from the renin lineage become green fluorescent protein positive. 23 All animals were handled in accordance with the National Institutes of Health guidelines for the care and use of experimental animals, and the study was approved by the Institutional Animal Care and Use Committee of the University of Virginia.
Blood Chemistry Measurements
Animals were anesthetized, and a blood metabolic panel was conducted as previously described.
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Morphometric Measurements
To determine arterial wall thickness, the external and internal diameters of arteries were measured in αSMA (α-smooth muscle actin)-stained sections. 
Quantification of YFP Cell Number in
Immunohistochemistry
Immunostaining for renin αSMA, Akr1b7 (aldo-keto reductase 1b7), and PECAM-1 (platelet endothelial cell adhesion molecule 1) was performed in kidneys harvested from 2-month-old mice as previously described. 15, 18, [24] [25] [26] [27] 
In Situ Hybridization
In situ hybridization was performed in 4% paraformaldehyde-, paraffinembedded kidney sections using a digoxigenin-labeled locked nucleic acid probe (Exiqon, Woburn, MA) specific for mouse miR-330-5p.
X-Gal Staining
To reveal the distribution of cells from the renin and smooth muscle lineage, we performed X-gal staining in Ren1 c -Cre;R26R.LacZ mice, as previously described.
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Statistical Analysis
Results are presented as means±SD. Statistical significance was determined using either Student t test or nonparametric tests as needed. Figure 1E , the number 
Results
Ren1
Histopathological Changes in the Kidneys of Ren1 c−/− Mice
To define the extent of histopathological differences between Ren1 c+/− and Ren1 c−/− mice, we performed immunostaining for αSMA, MHC (myosin heavy chain 11), and PECAM-1. Gross anatomic examination of the kidneys in Ren1 c−/− mice revealed a granular surface that was correlated histologically with marked interstitial fibrosis and tubular dilatation and atrophy ( Figure  2B ). The areas of fibrosis were positive for αSMA ( Figure 2B ). In addition to interstitial pathology, the kidneys from Ren1 c−/− mice displayed periglomerular fibrosis as detected by staining with the αSMA antibody ( Figure 2B and 2D) . Notably, the renal arteries and arterioles were thickened with cells that stained positive with the αSMA antibody ( Figure 2D ). The arteries and We quantified the arteriolar wall thickness of afferent arterioles in slides stained for αSMA (Figure 2A through 2E Figure 2E ). Given that the actual size and plane of cut of individual arterioles are somewhat variable, we also analyzed the data using relative frequency distribution histograms. Figure 2F shows that the distribution curve corresponding to the Ren1 c−/− animals was displaced to the right, indicating that a higher proportion of vessels possessed thicker walls than in control mice. We also evaluated the wall thickness of larger arteries with an internal diameter Figure S1 in the online-only Data Supplement). Again, the frequency distribution histogram clearly showed that a higher proportion of arterial vessels in Ren1 c−/− mice possessed thicker walls than in Ren1 c+/− mice ( Figure S1 ). Occasionally, the walls of larger arteries in Ren1 c−/− were irregular, protruding toward the lumen of the vessel ( Figure S1 ).
Renin Null Cells Express Akr1b7 and miR-330-5p, Markers of Cells Programmed for the Renin Phenotype
We have previously shown that Akr1b7 is a novel marker of cells programmed for the renin phenotype. 18 In fact, expression of Akr1b7 is maintained even when the cells are unable to synthesize renin, suggesting that Akr1b7 expression is part of the genetic program of the renin phenotype (Figure 3 ). Akr1b7-positive cells coincided with cells expressing αSMA in the outer layers of the arteriole ( Figure 3A and 3B, top) . In some vessels, although, Akr1b7+ cells were also distributed deeper inside the arteriolar wall ( Figure 3A and 3B, bottom) . Some Akr1b7+ cells were also observed in areas of periglomerular fibrosis. As expected in those areas of periglomerular fibrosis, αSMA expression was prominent. Occasionally, αSMA-and Akr1b7-positive cells were also present in portions of the intraglomerular and extraglomerular mesangial areas (not shown).
Next, we performed in situ hybridization for miR-330-5p, a renin cell marker expressed under conditions known to induce renin expression along the kidney vasculature. In contrast to Ren1 c+/− controls, miR-330-5p was highly expressed in the vessel walls and inside glomeruli in Ren1 c−/− kidneys, consistent with its presence when the renin program is activated ( Figure 3C and 3D) .
Distribution of Cells From the Renin Lineage in Ren1 c−/− Mice
We have reported that during normal development, renin precursors and their descendants are distributed along large intrarenal arteries, afferent arterioles, and inside glomeruli. 22 To define the contribution of cells from the renin lineage to the thickening of arterial walls, we performed fate tracing using Figure 4A and 4B, bottom) . However, the intramural arrangement of the cells was markedly different in knockout versus control animals: whereas in control animals, cells from the renin lineage arranged themselves in an organized circular pattern, cells from knockout animals were disorganized without a clear directional pattern (Figure 4B and 4D) . A similar disorganized pattern of renin null cells was also observed when examining them using the Lac-Z reporter ( Figure 4C ).
To define whether cells originating from endothelial progenitors could physically become part of the thickened arterioles, we studied EC-SCL-Cre ERT2 ;R26R.mTmG mice. We have shown that in these mice, expression of Cre and therefore green fluorescent protein is confined to cells of the endothelial progeny, including precursors and their descendants. 27 Results showed that the distribution of cells from the endothelial lineage was similar between Ren1 
Discussion
The present series of studies show that in renin knockout mice (1) there is concentric hypertrophy of the kidney arterioles leading to advanced kidney disease; (2) the cells programmed for the renin phenotype survive and increase in numbers along the renal arterial tree; (3) those renin null cells maintain the molecular program of the renin phenotype; and (4) renin null cells integrate in a chaotic, disorderly manner inside the vessel wall, thus contributing to the vascular disease. 
Pervasive Phenotype: Concentric Vascular Hypertrophy and Kidney Disease
Ren1
c−/− mice showed a distinct phenotype characterized by diminished kidney size, tubular atrophy and dilatation, marked periglomerular and interstitial fibrosis, and severe vascular disease. These morphological findings were accompanied by advanced renal failure, anemia, and splenomegaly. We speculate that the normocytic anemia is because of chronic renal failure and inability to synthesize or respond to erythropoietin as it has been suggested in patients with end-stage renal disease. Given that the mouse spleen retains hematopoietic capabilities throughout life, we assume that the splenomegaly is the result of a failed attempt to compensate for the anemia. Those findings are in agreement with previous work from several laboratories. 1, 29 With regards to the arterial lesions, we have shown that deletion of renin solely in the vasculature fully reproduces the entire morphological, physiological, and pathological manifestations (including the renal failure, hydronephrosis, and anemia) observed in renin knockout mice. 26 Deletion of renin in the tubular compartment does not lead to any obvious abnormalities. Thus, vascular renin is necessary to maintain the structural and physiological integrity of the kidney.
The vascular disease observed in our Ren1 c−/− mice was characterized by the presence of concentric and disorganized layers of renin lineage and smooth muscle cells that thickened the vessel walls and in some arterioles significantly narrowed their lumens. This lesion is not found solely in renin knockout mice. It is found in the kidneys of all the RAS gene knockout mice studied so far. 5, 30, 31 The same vascular lesion is also encountered in the kidneys of patients harboring mutations of the RAS genes 13 and in the kidneys of animals subjected to pharmacological inhibition of the RAS in early life 12, 32 or during the treatment of severe hypertension in adult rats. 33 This concentric vascular hypertrophy has been difficult to explain from a pathophysiological point of view because it resembles a similar lesion found in subjects with severe and chronic hypertension. 34 But animals and patients harboring mutations of the RAS genes or exposed to pharmacological inhibition of the RAS have low arterial pressure. It is well known that angiotensin is an angiogenic factor that could have contributed to the arteriolar thickening. 35 However, angiotensins I and II are undetectable in the circulation of Ren1 c−/− mice. 1 Furthermore, the same vascular lesions are found in animals with deletion of the source of all angiotensins, angiotensinogen −/− mice. 2, 3, 5, 36 The same lesions are also found in mice with combined deletion (or inhibition) of angiotensin type 1A and type 1B receptors. 9 In aggregate, those results indicate that in our study, the vascular lesions are unlikely to be because of angiotensin actions in the vasculature. Interestingly, when we ablated the renin cells by targeting diphtheria toxin into the renin gene, 14 the animals did not develop the arteriolar hypertrophy, suggesting that renin cells, directly, physically, or otherwise, were responsible for the vascular disease. For this hypothesis to be plausible, as discussed below, it required at a minimum that renin cells persisted in the kidney vasculature of Ren1 c−/− mice.
Cells Programmed for the Renin Phenotype Survive, Increase in Number Along the Renal Vasculature, and Maintain the Program for the Renin Phenotype
At first glance, it seemed conceivable that when cells are unable to perform their main function or to manufacture the protein that characterizes them, they would either undergo apoptosis or would not be replaced as the cells naturally aged and died. 35, [37] [38] [39] [40] [41] However, we did not find evidence of apoptosis. Instead and more importantly, using genetic fate tracing and immunostaining for Akr1b7 and in situ hybridization for miR-330-5p, we found that the renin null cells did not disappear. Instead, the cells survived and persisted throughout the kidney vasculature. Expression of Akr1b7, a marker of cells programmed for the renin phenotype, is of particular significance and deserves some comment: aldo-keto-reductase has been proposed to detoxify endocrine cells from harmful aldehydes-generated during periods of high protein synthesisto less toxic alcohols. The enzyme is highly enriched, almost as much as renin, in microarrays obtained from renin-synthesizing cells.
15 Akr1b7 is expressed with renin throughout development of renin-expressing cells and when differentiated, formerly renin-expressing cells (renin cell descendants) along the kidney vasculature re-enact the renin phenotype in response to physiological threats to homeostasis. This pattern of coexpression persists in extreme pathological situations, 18 and both enzymes, renin and Akr1b7, are regulated by cAMP in vitro and in vivo. In addition, we found that Ren1 c−/− mice expressed miR-330-5p along the kidney arterial tree. We have previously shown that expression of miR-330-5p occurs in juxtaglomerular cells when animals are exposed to angiotensin I-converting enzyme inhibitors and sodium depletion, 42 2 manipulations known to induce renin expression along the kidney vasculature. Those findings together with the results of the present experiments indicate that Akr1b7 and miR-330-5p (in addition to renin) are part of the conserved program of the renin cell phenotype. 29, 43 Furthermore, such genetic program is highly active in renin null cells. To provide further proof that the renin null cells were attempting to express renin, we studied mice harboring a transgene composed of the regulatory regions of the renin gene driving expression of YFP. Results showed that YFPexpressing cells were numerous and observed throughout the kidney arterial tree, including large corticomedullary vessels. Thus, renin null cells not only persisted but also their distribution and number along the renal arterial tree were expanded in a pattern that replicated the distribution of renin cells during fetal development and in response to physiological stress in adult animals. 17, 29, [44] [45] [46] [47] [48] The underlying mechanisms responsible for the renin null cells' attempt to maintain the endocrine phenotype of the native renin cell are intriguing. Renin cells are sensors designed to receive and respond to signals that convey the composition and volume of the extracellular fluid and the level of blood pressure. Under normal circumstances, renin synthesis and release are stimulated by a decrease in perfusion pressure, a decrease in sodium chloride at the level of the macula densa, and when the β-adrenergic receptors are stimulated by sympathetic activation. 49 In addition, renin synthesis and release are normally inhibited by angiotensin II.
Although not formally studied, in renin knockout mice (which are hypotensive, dehydrated, and lacking angiotensin), several or all of the major mechanisms that control renin synthesis and release are potentially activated in them, in an attempt to restore homeostasis. How those signals are transmitted to the genome to activate the renin gene and to restore the full endocrine phenotype of the renin cell is not fully clear although several key signaling mechanisms including but not limited to cAMP pathway, Notch receptors, and connexins are known be involved (reviewed in 31 ).
Renin null Cells Contribute to Vascular Pathology
In addition to encircling the arterioles, the intramural arrangement of the renin null cells was markedly different in knockout versus control animals: whereas in control animals, cells from the renin lineage were arranged in an organized circular pattern, cells from knockout animals were disorganized without a clear directional pattern. A similar disorganized pattern of renin null cells was observed whether the analysis was done using green fluorescent protein or Lac-Z reporting mice. The reasons for this particular intramural distribution are not clear and remain to be investigated. Nevertheless, the results of the present work suggest that renin cells per se contribute physically to the vascular hypertrophy. The results, however, do not exclude the distinct possibility that either the renin null cells that encircle the vessels or those located intramurally may produce some factor(s) that stimulated the growth of adjacent smooth muscle cells. In fact, from previous microarray data, we know that cells that are so continuously stimulated produce at least 14 different types of growth factors with the capability to induce smooth muscle growth. 15 Further work in this area will be necessary to identify the factor(s) involved.
A question remains about the possible mechanisms underlying such seemingly nonhomeostatic response from renin cells. During normal embryonic development, renin cells are distributed extensively along and throughout the renal arterial tree. 31 Given that Ren1 c−/− mice have a constant threat to homeostasis that becomes even more intense in extrauterine life (dehydration and hypotension), we hypothesize that the renin null cells are constantly stimulated to attempt renin synthesis. In the process, the cells are unable to mature and fully differentiate into smooth muscle cells, and as a consequence, the renin null cells and their progenitors retain their fetal characteristics and a molecular program driven not only to produce renin but also vascular growth because it occurs in early life ( Figure 5 ). 51 Further work will be needed to define whether the repertoire of genes expressed by renin null cells is similar to the pattern found in fetal-embryonic cells. More importantly, whether chronic pharmacological inhibition of the RAS in adult life leads to similar arterial and renal diseases needs to be determined. Given the widespread use of and efficacy of RAS inhibition in the treatment of Figure 5 . Schematic of Renin null cells contribution to vascular pathology. During normal development, renin precursors and their descendants are present along large intrarenal arteries, afferent arterioles, and inside glomeruli. In the normal adult mouse, renin cells become confined to the juxtaglomerular area. When the renin gene is knocked out, mice exhibit concentric hypertrophy of the kidney arterioles, leading to advanced kidney disease. The cells programmed for the renin phenotype survive and increase in numbers along the renal arterial tree. Those renin null cells maintain the molecular program of the renin phenotype, that is expression of renin cell markers Akr1b7, miR-330-5p, and YFP, and integrate in a disorderly manner inside the vessel wall, thus contributing to the vascular disease. Thus, renin null cells not only persist but also their distribution and number along the renal arterial tree are expanded in a pattern that replicates the distribution of renin cells during fetal development and in response to physiological stress in adult animals. Akr1b7 indicates aldo-keto reductase 1b7; EC, endothelial cell; GFP, green fluorescent protein; JG cell, juxtaglomerular cell; RPC, renin progenitor cell; SMC, smooth muscle cell; WT, wild type; and YFP, yellow fluorescent protein.
hypertension and other diseases and the pervasive vascular pathology that occurs when the RAS is ablated, it would be important to determine whether prolonged, full-blown, and aggressive inhibition of the RAS in humans with hypertension have similar effects or not.
Perspectives
Our results demonstrate that when concentric vascular hyperthrophy develops as a result of deletion of renin gene in the mouse, renin null cells survive, increase in number along the renal arterial tree, and maintain an active molecular memory of the renin phenotype. Furthermore, null cells of the renin lineage also occupy the walls of the arteries and arterioles in a chaotic, directionless pattern directly contributing to the concentric arterial hypertrophy. These observations stress the importance of determining whether prolonged and aggressive pharmacological inhibitions of the RAS leads to similar arterial and renal diseases.
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